People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bioarray Genetics, Inc. | — | Other Health Care | Series A | $6.7M | $105.3M | 2017 |
| Parcell Laboratories, Inc. | — | Biotechnology | Pre-Seed | $500K | $27.6M | 2014 |
Pamela Layton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Pamela Layton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick O'Neill | 1 | 14 |
| Pauline Murphy | 1 | 6 |
| Zafrira Avnur | 1 | 4 |
| Una Ryan | 1 | 4 |
| Henry Kay | 1 | 3 |
| John Garvey | 1 | 2 |
| Keith Crawford | 1 | 2 |
| Jim LaFrance | 1 | 1 |
| Michael Preminger | 1 | 1 |
| Marcia Fournier | 1 | 1 |
| Timothy Beals | 1 | 1 |
| Jeffrey Gadboys | 1 | 1 |
| Michal Preminger | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.